Values | ||
---|---|---|
Age | Range | (40–60) |
Mean±SD | 48.71 ± 5.01 | |
Disease duration | Range | (1–13) |
Mean±SD | 6.23 ± 3.14 | |
Subtype: | ||
dSSc | No. (%) | 18 (47.4%) |
lSSc | No. (%) | 20 (52.6%) |
Mouth opening (cm) | Range | (2–4) |
Mean ± SD | 3.07 ± 0.50 | |
Skin score (MRSS) | Range | (9–25) |
Mean ± SD | 15.23 ± 4.21 | |
HAQ-DI | Range | (0.4–1.7) |
Mean ± SD | 0.97 ± 0.36 | |
Xerostomia (VAS) | Range | (1–9) |
Mean ± SD | 3.39 ± 2.09 | |
Total MHISS | Range | (7–19) |
Mean ± SD | 12.21 ± 3.51 | |
Subscale 1 | Range | (4–10) |
Mean ± SD | 6.15 ± 1.60 | |
Subscale 2 | Range | (2–10) |
Mean ± SD | 4.6 ± 1.90 | |
Subscale 3 | Range | (0–4) |
Mean ± SD | 1.36 ± 1.195 | |
ILD | No. (%) | 15 (39.5%) |
PAH | No. (%) | 9 (23.7%) |
Kidney affection | No. (%) | 2/38 (0.05%) |
Oesophageal affection | No. (%) | 17 (44.7%) |
Musculoskeletal affection | No. (%) | 15 (39.5%) |
Raynaud’s phenomenon | No. (%) | 38 (100%) |
Telangiectasia | No. (%) | 10 (26.3%) |
Digital ulcer | No. (%) | 11 (28.9%) |
Hypo and hyper pigmentation | No. (%) | 5 (13.2%) |